UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors-What Some May Have Forgotten or Would Rather Forget?

ChemMedChem, 2016-01, Vol.11 (1), p.15-21

2016

Volltextzugriff (PDF)

A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)

Expert opinion on therapeutic patents, 2020-02, Vol.30 (2), p.121-136

2020

Volltextzugriff (PDF)

Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A

Journal of the American Chemical Society, 2010-08, Vol.132 (31), p.10842-10846

2010

Volltextzugriff (PDF)

Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection

Journal of medicinal chemistry, 2016-07, Vol.59 (13), p.6232-6247

2016

Volltextzugriff (PDF)

HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease

Nature medicine, 2011-08, Vol.17 (8), p.968-974

2011

Volltextzugriff (PDF)

Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth

Journal of medicinal chemistry, 2012-11, Vol.55 (22), p.9891-9899

2012

Volltextzugriff (PDF)

HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease

Brain (London, England : 1878), 2018-03, Vol.141 (3), p.673-687

2018

Volltextzugriff (PDF)

Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors

European journal of medicinal chemistry, 2021-01, Vol.209, p.112887-112887, Article 112887

2021

Volltextzugriff (PDF)

Structure−Activity Relationships for a Series of Quinoline-Based Compounds Active against Replicating and Nonreplicating Mycobacterium tuberculosis

Journal of medicinal chemistry, 2009-04, Vol.52 (7), p.2109-2118

2009

Volltextzugriff (PDF)

Chemical origins of isoform selectivity in histone deacetylase inhibitors

Current pharmaceutical design, 2008-02, Vol.14 (6), p.505-528

2008

Volltextzugriff (PDF)

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Nature communications, 2013-12, Vol.4 (1), Article 2907

2013

Volltextzugriff (PDF)

Epigenetic Regulation of Autophagy by the Methyltransferase G9a

Molecular and Cellular Biology, 2013-10, Vol.33 (20), p.3983-3993

2013

Volltextzugriff (PDF)

Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage Response

Clinical cancer research, 2019-11, Vol.25 (21), p.6452-6462

2019

Volltextzugriff (PDF)

Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function

Scientific reports, 2017-08, Vol.7 (1), p.8626-11, Article 8626

2017

Volltextzugriff (PDF)

A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome

Frontiers in cellular neuroscience, 2014-03, Vol.8, p.68-68

2014

Volltextzugriff (PDF)

Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3+ T-Regulatory Cells

Molecular and Cellular Biology, 2011-05, Vol.31 (10), p.2066-2078

2011

Volltextzugriff (PDF)

Development of Small Molecules that Specifically Inhibit the D‑loop Activity of RAD51

Journal of medicinal chemistry, 2016-05, Vol.59 (10), p.4511-4525

2016

Volltextzugriff (PDF)

Structural and in Vivo Characterization of Tubastatin A, a Widely Used Histone Deacetylase 6 Inhibitor

ACS medicinal chemistry letters, 2020-05, Vol.11 (5), p.706-712

2020

Volltextzugriff (PDF)

Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models

Journal of medicinal chemistry, 2019-09, Vol.62 (18), p.8557-8577

2019

Volltextzugriff (PDF)

Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains

Journal of medicinal chemistry, 2013-05, Vol.56 (10), p.4093-4103

2013

Volltextzugriff (PDF)

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Nature communications, 2013-12, Vol.4 (1), p.2907-2907

2013

Volltextzugriff (PDF)

Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus

Antimicrobial agents and chemotherapy, 2020-04, Vol.64 (5), p.AAC.02548-19

2020

Volltextzugriff (PDF)

Use of the Nitrile Oxide Cycloaddition (NOC) Reaction for Molecular Probe Generation: A New Class of Enzyme Selective Histone Deacetylase Inhibitors (HDACIs) Showing Picomolar Activity at HDAC6

Journal of medicinal chemistry, 2008-08, Vol.51 (15), p.4370-4373

2008

Volltextzugriff (PDF)

HDAC6 is a target for protection and regeneration following injury in the nervous system

Proceedings of the National Academy of Sciences - PNAS, 2009-11, Vol.106 (46), p.19599-19604

2009

Volltextzugriff (PDF)

Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot–Marie–Tooth Type 2A Mouse Model

Journal of medicinal chemistry, 2021-04, Vol.64 (8), p.4810-4840

2021

Volltextzugriff (PDF)

1 – 25 von 701

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(633)
Mit Volltextzugriff
(670)

Publikationsform

Sprache

Englisch
(697)
Deutsch
(4)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors-What Some May Have Forgotten or Would Rather Forget?

A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)

Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A

Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection

HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease

Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth

HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease

Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors

Structure−Activity Relationships for a Series of Quinoline-Based Compounds Active against Replicating and Nonreplicating Mycobacterium tuberculosis

Chemical origins of isoform selectivity in histone deacetylase inhibitors

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Epigenetic Regulation of Autophagy by the Methyltransferase G9a

Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage Response

Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function

A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome

Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3+ T-Regulatory Cells

Development of Small Molecules that Specifically Inhibit the D‑loop Activity of RAD51

Structural and in Vivo Characterization of Tubastatin A, a Widely Used Histone Deacetylase 6 Inhibitor

Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models

Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus

Use of the Nitrile Oxide Cycloaddition (NOC) Reaction for Molecular Probe Generation: A New Class of Enzyme Selective Histone Deacetylase Inhibitors (HDACIs) Showing Picomolar Activity at HDAC6

HDAC6 is a target for protection and regeneration following injury in the nervous system

Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot–Marie–Tooth Type 2A Mouse Model

Suchergebnisse filtern